Banner
-Text image
Boxes
-Text
Non-dilutive funding
The financing does not dilute the founders’ ownership stake, keeping motivation high, while complementing the equity capital.
Bespoke financing
Loans can be secured or unsecured and provide different levels of subordination (including contingent/participating loans).
Hands-off approach
The EIB assumes no direct involvement in daily management.
Signalling effect
The EIB’s financing is often seen as a quality stamp, helping the project attract additional investors.
Banner
-Text image
Accordion
-Static
Who is eligible
- SMEs and mid-caps
What is eligible
Investments in research & development (purchase or renovation of assets, increasing working capital, etc) which are undertaken over a period of up to 3 years. Minimum commitment of €7.5 million, covering a maximum of 50% of the total investment costs. Companies must be able to demonstrate sound corporate governance, viable business plans, and sustainable capital structures. The investments must target EIB priorities (especially Innovation and Skills).
Find information on pricing, geographical availability and other terms.
Financing options
Banner
-Text image
Banner
-Text image
Banner
-Text image
Banner
-Text image
Banner
-Text image
Boxes
-Card
Banner
-Text image
Accordion
-Static
Press releases
- Austria: EIB supports Innovacell’s innovative cell therapy for treating incontinence
- France: Lysogene enters into a loan agreement of €15 million with the EIB
- France: EIB lends €15 million to Quantum Surgical for the commercial launch of its Epione® medical robot
- France: eCential Robotics and EIB announce €15million in financing for research and innovation in digital and robotics for neuro-musculo-skeletal surgery
- Netherlands: Dutch med-tech innovator Xeltis lands €15 million European financing from EIB
- Greece/Cyprus: Next-generation insurance company Hellas Direct raises EUR 32 million and welcomes EIB backing
- Greece: Matrix Pack to receive EUR 8.5 million in support from EIB to focus all production on green single-use packaging
- France: EIB lends €7.5 million to Menta to speed up its development
- Germany: EIB and EIC Fund provide new funding for industry startup DyeMansion
- France: EIB provides €15 million to Robocath to support the development of its robotic solutions for treating cardiovascular disease
- Two companies empower small businesses and grow together
- Belgian med-tech innovator iSTAR Medical secures €20 million European financing from the EIB
- EIB invests in company Eggtronic's innovative technologies
- Investment Plan for Europe - EIB provides funding of up to EUR 20 million to Bitmovin
- D-Orbit brings tiny nano satellites to space for collecting climate change data
- Finland: Metaverse company Varjo receives €20 million in financing from EIB
- Spain: Anaconda Biomed to close venture debt operation of up to €10 million with the EIB to treat acute ischemic stroke (AIS)
- Germany: EIB provides €15 million of funding to IDnow
- Finland: TactoTek lands €15 mln venture debt financing under European Guarantee Fund
- Bulgaria: EIB invests €10 million in new space scaleup EnduroSat
- EIB Announces First Direct financing for a start-up in the European “New Space” sector - €20 million venture loan for Spire Global
- Netherlands: Dutch scale-up EclecticIQ receives €15 million in EU financing to boost development of next-gen cyber security platform
- Germany: EIB supports drone startup Quantum Systems with venture debt
- Lithuania: Long-term support for Brolis EIB venture debt from European Guarantee Fund
- Belgium: Belgian industrial biotech innovator Inbiose secures €15 million from EIB
- Belgium: EIB boosts innovative biotech company Univercells with €30 million of European financing to support COVID-19-related projects
- Belgium: Bone Therapeutics secures up to €16 million financing from EIB
- Austria: EIB provides €7.5 million to artificial intelligence software innovator Cortical.io
- France: EIB provides €50 million to support Forsee Power's growth
- France: OSE Immunotherapeutics enters a loan agreement of up to €25 million with the EIB
- France: EIB supports AB Science in its COVID-19 development programme
- Denmark: EU boosts Evaxion’s artificial intelligence vaccine research
- Germany: EIB provides KINEXON with €15 million to develop their internet of things technology
- Italy: EU backs MMI’s Robotic System for Microsurgery
- Sweden: EU backs cancer treatment research with quasi equity investment
- Spain: Biotech innovation - the EIB provides €20 million in financing to Sanifit to develop treatments for vascular calcification
- Poland: EIB lends up to €10 million to Scope Fluidics to develop diagnostics equipment for infectious diseases
- Italy: EU support for biotech’s red blood cell technology to treat rare diseases
- EIB signs collaboration with Israel Innovation Authority and €50 million financing agreement with Pluristem to develop therapies for COVID-19 and other unmet medical needs
- Netherlands: Europe supports AM-Pharma through EUR 24m InnovFin facility
- Slovenia: Investment Plan for Europe - EIB signs €12 million loan with energy services provider Resalta
- Germany: EIB provides funding of €40 million to ITM
- Poland: #InvestEU – EIB finances digital money transfer service Azimo to make international payments affordable to all
- France : Plan d’investissement - la BEI finance le développement de Famoco
- France: Median Technologies announces the signing of EUR 35 million finance contract with the EIB
- Germany: EIB provides funding of EUR 50 million to BioNTech as part of the Investment Plan for Europe
- Estonia: #InvestEU - EUR 50m quasi-equity facility for ride-hailing platform Bolt
- Germany: EU Investment Plan - EIB lends Fazua EUR 12 million